BNTX BioNTech

Watchlist

113.510
+0.430+0.38%

Close Dec 23 16:00 ET

113.510
0.0000.00%

Post 17:11 ET

27.21BMarket Cap-56.11P/E (TTM)

BioNTech Key Stats

According to the latest financial report of BioNTech, the latest earnings per share (TTM) for the company is 0.81. Investing in companies with strong earnings per share can potentially provide higher returns.

Currency: EUR

Quarterly

FCF

Interested in knowing about BioNTech's free cash flow? The latest report shows it as -721.90M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.

Currency: EUR

Quarterly

Current Ratio

If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of BioNTech shows that the company's current ratio is 7.33, indicating healthy liquidity.

Currency: EUR

Quarterly

Quick Ratio

Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of BioNTech, the quick ratio is 7.10, indicating that the company can meet its short-term debt obligations.

Currency: EUR

Quarterly

ROE

Want to learn more about the financial health of BioNTech? The latest ROE figure is 1.04%, indicating that the company has stable profitability.

Currency: EUR

Quarterly

ROA

Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of BioNTech, the total asset return on investment (ROA) is 0.89%.

Currency: EUR

Quarterly

Gross Margin

Gross margin can provide insight into a company's pricing strategy and cost structure. Check BioNTech's latest financial report to see how their gross margin is doing - currently at 85.63%.

Currency: EUR

Quarterly

Net Margin

For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of BioNTech, the net profit margin is 15.91%, which is a good sign for its profitability.

Currency: EUR

Quarterly

Trending US Stocks